Europe Antacid Market Report

Europe Antacid Market Size

The europe antacid market is anticipated to rise from USD 4.52 billion in 2024 to USD 6.60 billion in 2033, growing at a CAGR of 4.3%.

Antacids are a group of medications that help neutralize the content of acid reflux in the stomach. It provides fast relief of heartburn, one of the main symptoms of gastroesophageal reflux digestion, and other symptoms are nausea, bloating, or belching. Antacids include magnesium carbonate, aluminum hydroxide, and magnesium trisilicate. Some people have reported allergic reactions to antacids. Antacids incorporate magnesium carbonate, aluminum hydroxide, and magnesium trisilicate. A few people have announced unfavorably susceptible responses to antacids.

The growing trend toward self-medication is increasing the demand for over-the-counter digestive products to treat gastrointestinal disorders. Antacids are used to neutralize acidity and should therefore cause a dramatic increase in demand. According to a study conducted by the American Gastroenterological Association and published in the International Functional Foundation in February 2017, about one-third of the US population. Suffering from GERD. Market restraints include some side effects such as constipation, laxative effect, and allergic reactions. Also, people suffering from certain medical conditions are prone to adverse effects that worsen their state of health because people with heart disease may have problems due to the high amount of sodium present in antacids.

The market is segmented into the UK, Spain, Germany, France, and others by geography. It is occupying last second place in terms of market share. Among them, the UK and Germany have occupied the highest share. German has many investments compared to other regions.

KEY MARKET PLAYERS

Some of the Prominent Companies leading the European Antacid Market profiled in this report are GlaxoSmithKline plc, Abbott Laboratories, Pfizer, Inc., Sun Pharma, Digene (Abbott India), Pudin Hara (Dabur), and Gelusil (Pfizer).

MARKET SEGMENTATION

This research report on the Europe Antacid Market segmented and sub-segmented into the following categories and evaluated market size and forecast until 2025:

By Drug Class

• Proton Pump Inhibitors
• H2 Antagonist
• Acid Neutralizers
• Pro-motility Agents

By Formulation Type

• Tablet
• Liquid
• Powder

By Distribution Channel

• Hospital Pharmacies
• Retail Pharmacies
• Others

By Country

• United Kingdom
• France
• Spain
• Germany
• Italy
• Russia
• Sweden
• Denmark
• Switzerland
• Netherlands
• Rest of Europe